Use of azathioprine and the risk of cancer in inflammatory bowel disease. - Wikidata - wikimedia - TriplyDB

Use of azathioprine and the risk of cancer in inflammatory bowel disease.

Use of azathioprine and the risk of cancer in inflammatory bowel disease.

http://www.wikidata.org/entity/Q45132140

about

Oral pathology in inflammatory bowel disease Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis Glomerular diseases and cancer: evaluation of underlying malignancy.A disease spectrum for ITPA variation: advances in biochemical and clinical research Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective Use of thiopurines in inflammatory bowel disease: Safety issues.Thioguanine in inflammatory bowel disease: Long-term efficacy and safety Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.Inflammatory bowel disease cause-specific mortality: a primer for clinicians Primary enteric-type mucinous adenocarcinoma of the urethra in a patient with ulcerative colitis.Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis.Cancer and immunomodulators in inflammatory bowel diseases.Adverse symptoms with anti-TNF-alpha therapy in inflammatory bowel disease: systematic review and duration-response meta-analysis.IBD LIVE Case Series-Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?Effectiveness and Safety of Immunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease The continuing uncertainty about cancer risk in inflammatory bowel disease.Has the risk of colorectal cancer in inflammatory bowel disease decreased?Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-α therapy in inflammatory bowel disease.The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.Lymphoma presenting as secondary HLH: a review with a tale of two cases.Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.Toxicity and response to thiopurines in patients with inflammatory bowel disease.Oral Cancer and Oral Precancerous Lesions in Inflammatory Bowel Diseases: A Systematic Review.Mouth cancer in inflammatory bowel diseases.Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion.Chemoprevention of colorectal cancer in inflammatory bowel disease.Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study.Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease.Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine.Hydroxychloroquine and risk of cancer in patients with primary Sjögren syndrome: propensity score matched landmark analysis.Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.

P2860

Q26739055-439BFDA0-597E-4D6B-AEE3-36A756BF7EEE Q26745456-C6C4BE28-4413-4B81-B0DE-F653A14BA007 Q26746994-49DABE98-CE87-4272-8874-F99CE732F8EB Q26779686-BEFB3E19-476A-4E7B-BA3B-E7A513C98B74 Q28069352-C9BA9178-E5A8-4637-AEDA-5B502A6B5B06 Q28079644-6CC3F373-FCE2-458B-A111-525B151308F4 Q33621267-B2686474-9B25-4D16-8CC2-75779A6848E5 Q33731976-7915C0D3-CAB8-45CB-B6BE-C48DB3A6045A Q34062402-1605908C-A1F2-4DBB-9240-18B5C9882A31 Q34570452-0E38B409-140D-4280-B16C-76BD63272F36 Q34622042-3BA79785-0C85-4007-B0B4-AC9489BF292D Q34814602-914598C0-791C-428A-980B-BE34E9F9BD88 Q35060557-50D06112-890E-469A-8C0E-69C9106239C4 Q35534959-100147BC-99E9-41EA-9B24-DECC7E6BC670 Q35645531-04F69484-D8CC-4411-BC34-051AEF49A617 Q35670762-CC55CB51-4698-4F0F-80FA-7A662E498A86 Q35763489-724713E0-9B22-4FA6-AB1E-CBB33B17C2B3 Q37580031-733836F8-8CAE-4727-B664-3B1F48E369A0 Q38166711-9D7C8D34-2F67-4F25-8DB9-CE7A713E63D1 Q38180195-C29555D3-E9D3-4129-9DEE-5AB06E9AAF30 Q38224247-6C232F13-D4FE-464E-AC66-B58C79D15F85 Q38234358-6B992FAC-DB6D-4230-B11C-41B6B377CCD3 Q38253832-FBA70221-148D-47B2-AB85-E12B99CBBCAA Q38443981-BD4C64A7-16E2-403E-BD32-C2DA5280DD3C Q38545129-E8B6EC02-5CBC-4840-9826-FB484BE48E1E Q38670331-A832A70E-A907-462C-90CF-68C6C28C6722 Q38946338-4B49556F-B8EF-4D5B-91D2-23E82B704733 Q39016806-F7A5C9C7-6C77-4614-8A7F-04C27303912D Q39043418-0E8A3D0E-16F9-4A80-8ED6-8738726A2CD6 Q39119181-85FB8DF5-353C-4B5B-A87F-D9ACEA221B2C Q39435409-6E33CAEA-05FF-4CCC-A1D3-09951EB515EB Q39615429-2893BA7D-B98E-4FAF-B7FA-805F4928165A Q39783472-062A534E-F7FD-4E27-94C1-32990D52E895 Q40513902-4D924FF1-5BCF-4FF5-A6AA-EFFD4FBD7D76 Q41139928-3E4FC476-D01E-4C36-8C02-482518744B3B Q42463320-E0436911-09DD-447C-9804-CD3BA6CA9485 Q45397879-9ED334F8-7FA5-49C2-B763-B710CF8CBC5A Q46761838-32F5BCD2-FC0B-4EE3-9AD9-3472700870A4 Q47427964-04DB8ECC-D9F2-4AAD-8916-25D7950CC0F1 Q48002638-0E5ECCDA-C009-4C4B-9E01-25D2EAD88D5A

P2860

Use of azathioprine and the risk of cancer in inflammatory bowel disease.

http://www.wikidata.org/entity/Q45132140

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Use of azathioprine and the risk of cancer in inflammatory bowel disease.

@en

Use of azathioprine and the risk of cancer in inflammatory bowel disease.

@nl

type

label

Use of azathioprine and the risk of cancer in inflammatory bowel disease.

@en

Use of azathioprine and the risk of cancer in inflammatory bowel disease.

@nl

prefLabel

Use of azathioprine and the risk of cancer in inflammatory bowel disease.

@en

Use of azathioprine and the risk of cancer in inflammatory bowel disease.

@nl

P1433

Q45132140-CF06740D-65E0-4111-B937-443C00B8BD5E

P1476

Q45132140-955D2D44-F578-419F-8282-E96A04F6BC4D

P2093

Q45132140-168B5345-D1CC-474E-B2D4-12B84406F166

Q45132140-B6C9631F-24EB-492C-89C8-F65CB333B5DB

P2860

Q45132140-02970701-222D-409E-9566-370948A446C7

Q45132140-27589A4C-559D-42F6-B0FD-88651B3146B1

Q45132140-321E36E4-A4B0-4F9D-A1E6-2D44294FCC2C

Q45132140-3488E3B6-04F1-41C4-89EC-32859B3CAA44

Q45132140-3F0A8756-D4B3-47A9-8BAD-9290F2881FB7

Q45132140-41CE2CAE-9B8C-46FD-A5C1-AAF4CF7868BE

Q45132140-44304826-69FE-4377-A4C5-D7327AEFCF40

Q45132140-53FDBD20-1F1F-429E-9F81-BB668F27A80B

Q45132140-554681AB-183A-4AC4-801E-64D2622B87EC

Q45132140-5AD66E03-B6B3-404E-9021-050614555C04

P304

Q45132140-B71766E8-FE9C-43EB-8386-B0C338AB3562

P31

Q45132140-08FF8ACE-6870-49AF-9B15-77AD155B8DE2

P356

Q45132140-FF4E0D43-98CC-4C03-9496-D81FDC5A2896

P407

Q45132140-8B6A738C-27F6-4F48-9EA8-98CC2D94295F

P433

Q45132140-90FEF427-2352-4025-A785-60F4AD727639

P478

Q45132140-13B54BC7-948C-4DA7-906A-5F3D347A14AB

P50

Q45132140-24456F6E-FB6B-4B16-BB91-6ECBCF38F605

Q45132140-39E947EA-1172-421E-A499-0427A57A3A81

Q45132140-C9E5FE91-A033-4449-A051-DBEEC6AA32F9

P577

Q45132140-5D2879F3-6009-49FC-B3A4-9FD1D32BEBC6

P5875

Q45132140-7195DB36-4012-4B7D-A58D-6315AF267775

P698

Q45132140-E08A7C4B-7B55-4E39-8021-9F110C5D6538

P356

P1433

American Journal of Epidemiology

P1476

Use of azathioprine and the risk of cancer in inflammatory bowel disease.

@en

P2093

Henrik Svanström

http://www.w3.org/2001/XMLSchema#string

Tine Jess

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

A basic study design for expedited safety signal evaluation based on electronic healthcare data.

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

European evidence-based Consensus on the management of ulcerative colitis: Current management.

Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.

Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

P304

1296-1305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AJE/KWS375

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P50

Björn Pasternak

Kjeld Schmiegelow

P577

2013-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236066740

http://www.w3.org/2001/XMLSchema#string

P698

23514635

http://www.w3.org/2001/XMLSchema#string